Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TYMS | P04818 | 1/20 | 0.37 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.36 |
| ▸ | XDH | P47989 | 4/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27275712 | 0.86 | KDM4E (0.41) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL29150590 | 0.83 | KDM4E (0.41) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL32686177 | 0.82 | KDM4E (0.40) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL28068575 | 0.82 | GAA (0.40) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL28478046 | 0.82 | KDM4E (0.43) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL28176089 | 0.82 | KDM4E (0.40) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL1568354 | 0.82 | GAA (0.40) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL27511178 | 0.81 | KDM4E (0.40) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL3639474 | 0.81 | KDM4C (0.48) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL27483301 | 0.81 | KDM4E (0.38) | KDM4EGAAALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1156964-A | Novel Peptides | MERCK & CO INC (US) | 1997-08-13 | — | — | CN | claimed |
| CN-120078930-A | Synthetic tissue barrier and uses thereof | 麻省理工学院 | 2025-06-03 | — | — | CN | disclosed |
| CN-119698303-A | Methods for treating inflammatory conditions of the eye with IGF-1R ligands conjugated to disease modifying agents | 利鲁姆治疗公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-115066231-B | Synthetic tissue barrier and uses thereof | 麻省理工学院 | 2025-01-14 | — | — | CN | disclosed |
| CN-119080931-A | Anti-VLA-4 antibodies with reduced effector function | 马萨诸塞州渤健公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-112867394-B9 | Anti-VLA-4 antibodies with reduced effector function | 马萨诸塞州渤健公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-112867394-B | Anti-VLA-4 antibodies with reduced effector function | 马萨诸塞州渤健公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-115066231-A | Synthetic tissue barrier and uses thereof | 麻省理工学院 | 2022-09-16 | — | — | CN | disclosed |
| US-20220282207-A1 | FOLATE PRODUCING STRAIN AND THE PREPARATION AND APPLICATION THEREOF | CHIFENG PHARMACEUTICAL CO., LTD. (CN) | 2022-09-08 | — | — | US | disclosed |
| CN-114716313-A | Compounds for the treatment of rheumatoid arthritis | 重庆化工职业学院 | 2022-07-08 | — | — | CN | disclosed |
| CN-1989247-A | P2－10Expression unit | BASF AG (DE) | 2007-06-27 | — | — | CN | disclosed |
| CN-1307181-C | Fused heterocyclic succinimide compounds and analogs thereof that modulate nuclear hormone receptor function | BRISTOL MYERS SQUIBB CO (US) | 2007-03-28 | — | — | CN | disclosed |
| CN-1898388-A | PGRO expression unit | BASF AG (DE) | 2007-01-17 | — | — | CN | disclosed |
| CN-1894411-A | PSOD expression unit | BASF AG (DE) | 2007-01-10 | — | — | CN | disclosed |
| CN-1753694-A | Therapeutic agent for spinal cord injury comprising interleukin 6 antagonist | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2006-03-29 | — | — | CN | disclosed |
| CN-1608069-A | Fused heterocyclic succinimide compounds and analogs thereof that modulate nuclear hormone receptor function | BRISTOL MYERS SQUIBB CO (US) | 2005-04-20 | — | — | CN | disclosed |
| CN-1589271-A | Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function | BRISTOL MYERS SQUIBB CO (US) | 2005-03-02 | — | — | CN | disclosed |
| CN-1585822-A | Polycistronic expression of antibodies | IDEC PHARMA CORP (US) | 2005-02-23 | — | — | CN | disclosed |
| CN-1570135-A | Homotype cysteine detecting method adopting micromolecule trapping technology | BEIJING JIUQIANG BIOTECHNOLOGY (CN) | 2005-01-26 | — | — | CN | disclosed |
| CN-1156964-A | Novel Peptides | MERCK & CO INC (US) | 1997-08-13 | — | — | CN | disclosed |